The COVID-19 pandemic may be over, but our immune systems are still feeling the impact. After years of battling constant viral threats, from COVID-19 to seasonal flu and other infections, our body’s defense system is exhausted. Many people continue to experience lingering inflammation, frequent illnesses, and slower recovery times. This extended state of immune stress has compromised us further to chronic illness, including autoimmune diseases and even neurodegenerative diseases such as Parkinson's. So why is our immune system still in trouble? And how do we give it its power back? Understanding immune exhaustion is the beginning of rebuilding our body's natural immunity.
A weakened immune system makes people more susceptible to disease, mental illnesses, and even sleep disorders. Now, new research indicates that immune system depletion may play an important role in the onset of Parkinson's disease, a degenerative neurologic disorder that compromises movement and cognition.
Dysfunctional immune response is a leading cause of long-standing inflammation within the body, that has been found to contribute towards a multitude of conditions, including cardiovascular conditions, diabetes, depression, and neurodegenerative diseases such as Alzheimer's.
As people age, their immune system naturally becomes less effective. This deterioration, referred to as immune exhaustion, may be a key contributor to the onset and progression of Parkinson’s disease. Rebecca Wallings, a Parkinson’s Foundation Launch Award grant recipient and senior postdoctoral fellow at the University of Florida, believes that an accumulation of exhausted immune cells could be driving neurodegeneration in Parkinson’s patients.
Parkinson's disease is most commonly linked with the degeneration and loss of dopaminergic neurons—motor nerve cells that produce dopamine, an essential neurotransmitter for movement. While researchers have long suspected inflammation is involved in this neurodegeneration, the mechanisms are not yet well understood.
Wallings' study is on immune cell exhaustion, a process by which aging immune cells fail to control immune responses effectively. Her research indicates that instead of dampening inflammation in Parkinson's patients, attempts should be made to rejuvenate the immune system to regain its functionality.
One of the major findings of Wallings' work is the function of mitochondrial impairment in immune cell exhaustion. Mitochondria are commonly called the powerhouses of cells, as they are vital for generating energy. As mitochondria age and become inefficient, immune cells fail to function well, potentially accelerating neurodegeneration in Parkinson's disease.
Wallings has found that mutations in the LRRK2 gene, a recognized genetic risk factor for Parkinson's disease, are linked with defective mitochondrial function and immune cell exhaustion. Her current work includes testing various therapeutic approaches to restore mitochondrial function in immune cells with the potential to enhance the immune system and potentially prevent or treat Parkinson's disease.
For decades, the standard practice in treating Parkinson's has been to suppress brain inflammation. Yet Wallings' work indicates that instead of slowing down immune responses, restoring the immune system could be a more successful strategy. By addressing mitochondrial impairment and immune resilience, researchers can potentially reverse or slow down Parkinson's disease.
Wallings is now looking into how to rejuvenate immune cells by fixing mitochondria. She studies immune cells from patients with Parkinson's as well as from healthy subjects and performs experiments on animal models to determine if rejuvenation of the immune system could result in improved disease outcomes.
While there is no cure for Parkinson's disease, some lifestyle adjustments may decrease the chances of developing the illness. Since neurodegenerative diseases are associated with chronic inflammation and immune dysfunction, developing habits that enhance immune function might prove helpful.
Diet: There is evidence to suggest that eating in accordance with the Mediterranean or MIND diets, both high in antioxidants, healthy fats, and anti-inflammatory foods, can encourage brain wellness and reduce Parkinson's risk.
Avoiding Dangerous Substances: Restricting alcohol and nicotine use can maintain a robust immune system and suppress inflammation.
Reducing Stress: Chronic stress weakens immune function, so methods such as meditation, exercise, and sufficient sleep can lead to improved overall well-being.
Credits: Canva
For many young and middle- aged adults, headaches or brief dizzy spells often feel routine — attributed to long work hours, stress, or poor sleep. Occasional blackouts or “spacing out” episodes may be brushed aside as fatigue or skipped meals.
What makes these symptoms particularly dangerous is that they are often mistaken for burnout, stress, migraines, or exhaustion — especially among younger working professionals. While most headaches are harmless, persistent neurological symptoms that disrupt daily life should never be ignored.
But there are neurological symptoms you should never ignore: sudden seizures, memory loss after brief collapse, repeated headaches, unexplained weakness, or changes in personality. These can sometimes point to an underlying brain disorder — and, in rare cases, to Glioblastoma, one of the most aggressive forms of brain cancer.
Glioblastoma (GBM) is one of the most aggressive and fast-growing forms of brain cancer in adults. It develops in the supportive tissue of the brain and can quickly affect memory, speech, movement, personality, and other neurological functions. Because the tumour tends to spread into nearby healthy brain tissue, complete surgical removal is often difficult, making timely diagnosis and treatment extremely important. While brain tumours are often associated with older adults, specialists are increasingly seeing younger individuals dismiss early warning signs as work-related fatigue, lack of sleep, stress, or lifestyle burnout. Delayed recognition can sometimes postpone critical medical intervention. In India, there are around 23,000 glioblastoma cases per day, considered higher incidence rates along with North America, Australia, Northern and Eastern Europe. Seizures and persistent headaches are often among the earliest symptoms that prompt medical investigation.
Recently, a 34-year-old woman presented to Apollo Hospitals, Bannerghatta with seizures and memory loss. Her first seizure occurred one morning at home — she collapsed briefly, with twisting of arms and legs, and woke with total memory loss of the episode. Like many young professionals struggling between work and personal commitments, she first considered the cause to be work-induced stress. The family did not suspect that these seemingly routine headaches and blackouts could indicate a serious neurological condition. Before that, she had minor headaches — the kind most people ignore. An MRI scan revealed brain swelling, and anti-seizure medication was prescribed. A second opinion at month’s end showed swelling reduction.
The turning point came in late, during a road trip, when she suffered three seizures in two hours. A burr hole biopsy of a right frontal lesion suggested a diffuse low-grade glioma. Subsequent evaluations at Apollo Hospitals upgraded the diagnosis to bifrontal Glioblastoma — a clinically challenging case due to its location. This is a clinically unusual case because most of the time, GBM is diagnosed with MRI with contrast, MR spectroscopy, and biopsy to confirm the type and grade of tumor. In this patient’s case, imaging revealed widespread bifrontal involvement — making conventional surgery high risk. Her care team opted for a non-surgical precision radiotherapy approach. She had 25 high precision image guided radiotherapy (IGRT) sessions using RapidArc technology. This was followed by two CyberKnife boost sessions to high-risk tumour areas - a plan to boost treatment precisely where it was most needed. All sessions went smoothly, with no major side effects. Since October 2024, she has been undergoing her cycle of monthly chemotherapy treatment alongside her regular scanning.Happily, she was also able to slowly get back to work, engage in recreational activities, and gain a semblance of normal life despite the ongoing cancer treatment.
Signs that point to headaches along with seizures, vomiting, blurred vision, confusion, personality changes, weakness, or an increasing frequency of symptoms should be evaluated medically without delay. Even one seizure is not an issue to ignore.
Some symptoms you must mention to your doctor will be:
It may help you diagnose your problems effectively if you see a neurologist, conduct MRI brain imaging and have consultations from an early stage. While some headaches or seizures do not necessarily mean having a tumor in the brain, regular occurrence of such symptoms with no reason is likely to be examined by an expert. However, although a proper healthy lifestyle may help your brain remain healthy, it will be ineffective for illnesses like GBM.
Credits: Canva
Glomerular Diseases affect the glomeruli, which are very small filtering units in the human kidney, and when they get damaged due to disorders, the filters leak blood and vital proteins into the urine and fail to remove waste efficiently. Eventually, these problems can lead to chronic kidney disease or kidney failure. As per its treatment, medications are used to slow kidney damage, manage blood pressure, and reduce protein leakage.
Notably, a new study has revealed hope in this condition by finding that a well-known drug can be very effective in slowing damage if the patient has Glomerular Diseases, and that common drug is Finerenone, which is often prescribed for heart and kidney diseases associated with type 2 diabetes.
The trial was participated in by 903 participants with glomerular diseases. The drug finerenone was given to them. The results show that compared with placebo, it slowed kidney damage, reduced albuminuria, and lowered the risk of kidney failure or sustained loss of kidney function.
Thus, the study clearly indicates that the drug called finerenone may play an important role in protecting kidney function in patients with glomerular diseases.
The research was conducted through subgroup analysis of a phase 3, randomized, double-blind, placebo-controlled trial conducted across 24 countries and regions, focusing on participants with an investigator-reported glomerular disease.
The study was conducted on a large scale, having conducted the research for months in 24 countries and regions. The trial also took care of other important details and implemented all required paperwork, thus securing approvals by regulatory authorities along with ethics committees in every center. Other than that, the participants were required to submit written informed consent. Moreover, an independent data monitoring committee performed safety monitoring throughout the tests.
Dietary habits can contribute to kidney strain, particularly when busy schedules encourage reliance on convenient foods that are often high in sodium and low in nutritional value.
Hydration habits are additional concerns among office workers. Many professionals rely heavily on coffee, energy drinks, or sugary beverages during long workdays, often replacing plain water as the main source of fluid intake.
Protecting kidney health often begins with small lifestyle changes. Reducing processed food consumption, limiting excessive salt intake, staying adequately hydrated, and maintaining regular sleep schedules can all support kidney function.
Taking short movement breaks during long work hours and managing stress through regular physical activity or relaxation techniques may also help reduce the long-term strain that modern work routines place on the body.
Credit: AI generated image
Convenience foods have become the defining feature of urbanization. From ready-to-eat breakfasts to microwavable dinners and takeaway lunches, packaged food fits into all our lives.
But behind this convenience, what lies underneath are the tiny plastic particles, also referred to as microplastics, which are accentuating health concerns across the globe. Unknowingly, these microplastics are seeping through the plastic cutlery, food packaging, etc., potentially into our bodies. Plastics have been widely used for ages due to their higher affordability, durability, and extensive applications in various industries.
As per a recent literature quoted by Zhang et al. 2025, only about 20% of the plastic waste produced is recycled, whereas the rest is either abandoned in landfills or dispersed into the environment. Microplastics are the new emerging pollutant category in the modern era, raising prominent concerns in both health & environmental contexts. As per scientific literature, microplastics are plastic fragments with a diameter of less than 5mm.
Plastic food packaging dominates the global food system, since it can be designed in any form (container, wrapper, pouch, etc) while keeping food fresh for longer periods.
Microplastics are released from food packaging(s), especially when they are exposed to prolonged heat, abrasive forces, and undue environmental stresses. Heating and/or reheating food in plastic containers or choosing to decant packaged food commodities in plastic containers and maintaining them under unfavorable circumstances can all increase the likelihood of microplastic release.
Bottled water has also proven to release thousands of microplastic particles into the water they contain when exposed to sunlight/ heat. We never give a thought to such bottles being sold by the roadside vendors, wherein these plastic bottles are hung for indefinite days on that kiosk.
Those bottles are in constant light exposure all day without even pondering about the ill effects it may cause to the consumers. Similarly, single-use tea bags have also been shown to release billions of microplastics when steeped in hot water. These findings highlight a troubling paradox that products marketed for convenience and safety may be introducing new risks that consumers never thought about.
The health implications of ingesting microplastics remain an active area of research, but early findings are enough to raise concerns. Studies have demonstrated microplastics in human blood, lungs, and even placental tissue. This suggests that upon ingestion, these particles may not simply pass through the body. Instead, they would accumulate in tissues or interact with biological systems in ways that are not yet fully explored.
One of the major health implications pertaining to microplastic ingestion is inflammation. These particles can trigger irritation in tissues, eventually impacting the immune responses.
Plastics often contain additives in the form of plasticizers, etc., which may disrupt hormone function and impair the normal cellular function.
Infants and children are more often vulnerable as their food is also packed in plastic packaging or containers (like plastic sippers, feeding bottles, baby food pouches, etc.), raising long-term exposure risk during critical stages of growth.
The issues relating to plastic usage also reflect a broader tension in the modern era, where convenience seems to intersect with health! For people or families juggling work and financial burdens, avoiding packaged foods mostly sounds unrealistic.
Still, some small and consistent actions can help us reduce the exposure to microplastics, like opting for glass or paper packaging wherever possible. Avoiding heating food in plastic containers or opting for biodegradable packaging options could prove to be beneficial in the future. Though microplastics are invisible to our naked eyes, what we do next to curb them would help us shape a healthy future.
© 2024 Bennett, Coleman & Company Limited